Evidence map›Paper›PMID 33489698›Full record

ArticleInternational cancer conference journal2021

Whole brain radiation therapy for primary central nervous system marginal zone lymphoma: a case report.

Genki Edward Sato, Itaru Ikeda, Marie Sakoda, Kiyotomo Matsugi, Takahiko Utsumi, Yoko Iwasa, Chikako Yamauchi

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International cancer conference journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Genki Edward SatoDepartment of Radiation Oncology, Shiga General Hospital, 5-4-30 Moriyama, Moriyama, Shiga 524-8524 Japan.
Itaru IkedaDepartment of Radiation Oncology, Shiga General Hospital, 5-4-30 Moriyama, Moriyama, Shiga 524-8524 Japan.
Marie SakodaDepartment of Radiation Oncology, Shiga General Hospital, 5-4-30 Moriyama, Moriyama, Shiga 524-8524 Japan.
Kiyotomo MatsugiDepartment of Radiation Oncology, Shiga General Hospital, 5-4-30 Moriyama, Moriyama, Shiga 524-8524 Japan.
Takahiko UtsumiDepartment of Haematology and Oncology, Shiga General Hospital, 5-4-30 Moriyama, Moriyama, Shiga 524-8524 Japan.
Yoko IwasaDepartment of Pathology, Shiga General Hospital, 5-4-30 Moriyama, Moriyama, Shiga 524-8524 Japan.
Chikako YamauchiDepartment of Radiation Oncology, Shiga General Hospital, 5-4-30 Moriyama, Moriyama, Shiga 524-8524 Japan.
Shiga Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A standard radiation therapy protocol for primary central nervous system marginal zone lymphoma (CNS-MZL) has not been established. The International Lymphoma Radiation Oncology Group suggested a radiation therapy dose of 30-36 Gy for lesions of well-defined CNS-MZL. We report a case of relatively low-dose whole brain radiation therapy (WBRT) for ill-defined CNS-MZL. A 56-year-old man who presented with sudden left-sided convulsions and impaired consciousness was diagnosed with CNS-MZL. The tumor had an ill-defined lesion, without cerebrospinal fluid involvement. WBRT, consisting of 25.2 Gy in 14 fractions, was administered owing to the difficulty in target delineation for focal radiation therapy. No chemotherapy was administered during the treatment course. After the 36-month follow-up period, the patient maintained complete remission without neurological disorders. This report describes the usefulness of relatively low-dose WBRT for ill-defined CNS-MZL.

Indexed as

CNS lymphomaDural lymphomaMALT lymphomaMarginal zone lymphomaWhole brain radiation therapy

Identifiers

PMID33489698
PMCPMC7797388
OpenAlexW3084209443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.